美国风湿病学会对风湿与骨骼肌肉疾病患者COVID-19疫苗接种的指导(第一版)
美国风湿病学会组建工作组,基于有限直接证据,采用改良Delphi法和RAND/UCLA适宜性方法,经两轮迭代就74条指导声明达成共识,为风湿与骨骼肌肉疾病患者使用COVID-19疫苗及围接种期免疫调节治疗的使用和时机提供指导。
要点
- 74条共识声明指导RMD患者COVID-19疫苗接种。
- 涵盖围接种期免疫调节治疗的使用与时机建议。
- 证据有限,共识基于改良Delphi法和RAND/UCLA方法。
核心结论
- 在直接证据有限背景下,工作组就74条指导声明达成共识,为RMD患者COVID-19疫苗接种及围接种期免疫调节治疗提供方向。
研究设计与样本
- 工作组包括9名风湿病学家/免疫学家、2名感染病专家和2名公共卫生医师,采用改良Delphi过程和RAND/UCLA适宜性方法经2轮会议迭代对草案声明评分并确定共识。
主要发现
- 工作组制定74条草案指导声明,并基于评分分布达成共识。
关键数值与推荐
- 共识声明采用9分制数值评分系统评定同意程度。
临床怎么用
- 指导风湿科医疗提供者在RMD患者中最佳使用COVID-19疫苗并促进疫苗接种策略实施。
局限性
- 直接证据匮乏,指导声明是在有限临床数据背景下制定的。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To provide guidance to rheumatology providers on the use of coronavirus disease 2019 (COVID-19) vaccines for patients with rheumatic and musculoskeletal diseases (RMDs). METHODS: A task force was assembled that included 9 rheumatologists/immunologists, 2 infectious disease specialists, and 2 public health physicians. After agreeing on scoping questions, an evidence report was created that summarized the published literature and publicly available data regarding COVID-19 vaccine efficacy and safety, as well as literature for other vaccines in RMD patients. Task force members rated their agreement with draft consensus statements on a 9-point numerical scoring system, using a modified Delphi process and the RAND/University of California Los Angeles Appropriateness Method, with refinement and iteration over 2 sessions. Consensus was determined based on the distribution of ratings. RESULTS: Despite a paucity of direct evidence, 74 draft guidance statements were developed by the task force and agreed upon with consensus to provide guidance for use of the COVID-19 vaccines in RMD patients and to offer recommendations regarding the use and timing of immunomodulatory therapies around the time of vaccination. CONCLUSION: These guidance statements, made in the context of limited clinical data, are intended to provide direction to rheumatology health care providers on how to best use COVID-19 vaccines and to facilitate implementation of vaccination strategies for RMD patients.
引用
- Curtis JR, Johnson SR, Anthony DD, et al. American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 1. Arthritis Rheumatol. 2021. PMID: 33728796. doi:10.1002/art.41734
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。